September 8, 2022
Ascendia Pharmaceuticals is pleased to announce it has been named to the prestigious Inc. 5000 rankings of the fastest growing […]
READ MORE >
Sophisticated formulations in every stage of development from MOLECULE to FORMULATION to CLINICAL 
Our Technologies
EMULSOL
AMORSOL
NANOSOL
A wide array of pharmaceutical development capabilities for manufacturing and
analyzing drug product dosage forms. READ MORE >
FEATURED
Ascendia Solidifies Leading CDMO Position By Ranking on Inc. 5000 List Again
Ascendia Pharmaceuticals solidified its position as a leading pharmaceutical contract formulation development and manufacturing organization (CDMO) by once again being […]
READ MOREPARTNERING WITH ASCENDIA
Ascendia provides its partners rapid, comprehensive and cost-effective
solutions for their difficult formulation development projects. LEARN MORE >
ASCENDIA NEWSROOM
August 22, 2022
Six years ago, two-thirds of all drugs in the development pipeline were small molecules. Today, while still leading the market, […]
READ MORE >July 28, 2022
Ophthalmic formulation development is receiving more attention in the pharmaceutical industry as of late thanks to advances in technology, increasing […]
READ MORE >